Contemporary surgical and procedural management of benign prostatic hyperplasia

被引:2
|
作者
Sotimehin, Ayodeji E. [1 ,3 ]
Haile, Eiftu [1 ]
Gill, Bradley C. [2 ]
机构
[1] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH USA
[2] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH USA
[3] Cleveland Clin, Glickman Urol & Kidney Inst, Q10-125G,9500 Euclid Ave, Cleveland, OH 44195 USA
关键词
HOLMIUM LASER ENUCLEATION; URINARY-TRACT SYMPTOMS; PRESERVING SEXUAL FUNCTION; TRANSURETHRAL RESECTION; PHOTOSELECTIVE VAPORIZATION; URETHRAL LIFT; TRANSVESICAL PROSTATECTOMY; FUNCTIONAL OUTCOMES; ERECTILE FUNCTION; RANDOMIZED-TRIAL;
D O I
10.3949/ccjm.90a.23026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interventions for benign prostatic hyperplasia have evolved from transurethral resection of the prostate and simple prostatectomy to a myriad of office-based and operating-room procedures. The contemporary approach involves matching the right procedure to the right patient, choosing on the basis of prostate characteristics, patient preference, and urologist expertise. This review details currently available and guideline-backed surgical and procedural treatments.
引用
收藏
页码:745 / 753
页数:9
相关论文
共 50 条
  • [41] SURGICAL TECHNIQUES, BENIGN PROSTATIC HYPERPLASIA, PHYSIOLOGY
    HOHENFELLNER, M
    MUSCHTER, R
    AKTUELLE UROLOGIE, 1995, 26 : 99 - 99
  • [42] SURGICAL-TREATMENT FOR BENIGN PROSTATIC HYPERPLASIA
    BRENDLER, C
    SCHLEGEL, P
    DOWD, J
    KIRBY, R
    ZATTONI, F
    CANCER, 1992, 70 (01) : 371 - 373
  • [43] CONTEMPORARY ACTIVE CLINICAL TRIALS IN BENIGN PROSTATIC HYPERPLASIA
    Buford, Karis
    Polland, Allison
    Khurgin, Jacob
    Chughtai, Bilal
    Teper, Ervin
    Silver, David
    Schulman, Ariel
    JOURNAL OF UROLOGY, 2019, 201 (04): : E372 - E372
  • [44] UroLift and Rezum: minimally invasive surgical therapies for the management of benign prostatic hyperplasia
    Leong, Joon Yau
    Tokarski, Anthony T.
    Roehrborn, Claus G.
    Das, Akhil K.
    CANADIAN JOURNAL OF UROLOGY, 2021, 28 : 2 - 5
  • [45] Body Mass Index Predicts Failure of Surgical Management in Benign Prostatic Hyperplasia
    Willder, Jennifer M.
    Walker, Victoria C.
    Halbert, Gwen L.
    Dick, Craig P. C.
    Orange, Clare
    Qayyum, Tahir
    Horgan, Paul G.
    Underwood, Mark A.
    Edwards, Joanne
    UROLOGIA INTERNATIONALIS, 2013, 90 (02) : 150 - 155
  • [46] Trends in the pharmacological and surgical management of benign prostatic hyperplasia: population based data
    Perera, M.
    Roberts, M.
    Williams, M.
    Ranasinghe, S.
    BJU INTERNATIONAL, 2018, 121 : 13 - 14
  • [47] Re: Trends and Attitudes in Surgical Management of Benign Prostatic Hyperplasia Editorial Comment
    Kaplan, Steven A.
    JOURNAL OF UROLOGY, 2012, 188 (06): : 2313 - 2314
  • [48] Opportunity to Optimize Management of Benign Prostatic Hyperplasia
    Zarowitz, Barbara J.
    GERIATRIC NURSING, 2010, 31 (06) : 441 - 445
  • [49] SEXUALITY AND MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA WITH ALFUZOSIN
    Hwang, T. I. S.
    Chiang, P. H.
    Lin, M. S.
    Chen, C. S.
    Lee, L. M.
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 93 - 93
  • [50] Optimising the medical management of benign prostatic hyperplasia
    McDermott, T
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1997, 51 (02): : 116 - 118